title: Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
authors.affiliation: University of Perugia, Department of Internal Medicine, Section of Internal Medicine, Endocrinology, and Metabolism, via E. Dal Pozzo, 06126 Perugia, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Porcellati
authors.forename: Paolo
authors.initials: P
authors.lastname: Rossetti
authors.forename: Natalia Busciantella
authors.initials: NB
authors.lastname: Ricci
authors.forename: Simone
authors.initials: S
authors.lastname: Pampanelli
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Torlone
authors.forename: Susana Hernandez
authors.initials: SH
authors.lastname: Campos
authors.forename: Anna Marinelli
authors.initials: AM
authors.lastname: Andreoli
authors.forename: Geremia B
authors.initials: GB
authors.lastname: Bolli
authors.forename: Carmine G
authors.initials: CG
authors.lastname: Fanelli
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008297:Male; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine